MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Artificial Intelligence based detection of Parkinson’s disease in Magnetic Resonance Imaging brain scans

M. Courtman, M. Thurston, L. Mcgavin, C. Carroll, L. Sun, E. Ifeachor, S. Mullin (Plymouth, United Kingdom)

Meeting: 2022 International Congress

Abstract Number: 138

Keywords: Magnetic resonance imaging(MRI), Parkinson’s

Category: Parkinson's Disease: Neuroimaging

Objective: To use an artificial intelligence (AI) based framework to detect Parkinson’s disease (PD) in Magnetic Resonance Imaging (MRI) brain scans.

Background: Candidate neuroprotective treatments for PD are highlighting the need for early diagnostic tests, as timely intervention would require early detection. A number of exploratory imaging techniques have suggested that early pathological brain changes may be possible to detect using dedicated experimental MRI sequences. We explored whether machine learning (ML) might be employed to detect such brain changes on routine MRI scans, as routine brain imaging would provide a cost-effective means of screening for PD. A subset of ML known as deep learning (DL) has shown great promise in diagnostic medical imaging, sometimes matching or even exceeding the diagnostic performance of radiologists. DL offers the potential of automated diagnosis by detecting patterns that might be invisible to the human eye. DL methods have sometimes been criticised for being “black boxes”, but newly emerging explainability methods in the field of AI are allowing the decisions made by DL models to be better interpreted by practitioners.

Method: We trained a convolutional neural network to classify 138 PD and 60 control brain MRI images acquired from the Parkinson’s Progression Marker Initiative (PPMI) database. Models were assessed using 5-fold cross-validation. We used Deep SHapley Additive exPlanations (DeepSHAP) to calculate and visualise the contribution of individual pixels to the model’s prediction.

Results: A model was developed using a combined dataset of axial T2 and proton density MRI scans, which classified images with 79% accuracy and a Receiver Operating Characteristic area under the curve (AUC) of 0.86. Another model was trained on just T2 scans, and classified images with 81% accuracy and AUC of 0.83. A further model was trained on just proton density scans, and classified images with 84% accuracy and AUC of 0.88. The heatmaps generated using Shapley values demonstrated predominant contribution to the prediction in the midbrain slices.

Conclusion: Our models exhibited good diagnostic performance. The use of explainable AI highlighted regions of interest consistent with the known neuropathology of PD, providing a focus for future work. We will validate these models in a large dataset of routinely collected NHS MRI scans, many of which precede onset of motor symptoms.

To cite this abstract in AMA style:

M. Courtman, M. Thurston, L. Mcgavin, C. Carroll, L. Sun, E. Ifeachor, S. Mullin. Artificial Intelligence based detection of Parkinson’s disease in Magnetic Resonance Imaging brain scans [abstract]. Mov Disord. 2022; 37 (suppl 2). https://www.mdsabstracts.org/abstract/artificial-intelligence-based-detection-of-parkinsons-disease-in-magnetic-resonance-imaging-brain-scans/. Accessed June 12, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2022 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/artificial-intelligence-based-detection-of-parkinsons-disease-in-magnetic-resonance-imaging-brain-scans/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley